Identification | Back Directory | [Name]
4-TRIFLUOROMETHYL-N-METHYLANILINE 97 | [CAS]
22864-65-9 | [Synonyms]
Fluoxetine impurity FXT-V N-Methyl-4-(trifluoromethyl) 4-(Methylamino)benzotrifluoride N-Methyl-p-trifluoromethylaniline 4-(Methylamino)benzotrifluoride 98% 4-TRIFLUOROMETHYL-N-METHYLANILINE 97 4-(Trifluoromethyl)-N-methylaniline 97% BenzenaMine, N-Methyl-4-(trifluoroMethyl)- n-methyl-n-[4-(trifluoromethyl)phenyl]amine 4-(TRIFLUOROMETHYL)-N-METHYLANILINE, 97% MIN. | [EINECS(EC#)]
245-739-1 | [Molecular Formula]
C8H8F3N | [MDL Number]
MFCD07369717 | [MOL File]
22864-65-9.mol | [Molecular Weight]
175.15 |
Chemical Properties | Back Directory | [Boiling point ]
105-106 °C20 mm Hg(lit.)
| [density ]
1.2394 g/mL at 25 °C(lit.)
| [refractive index ]
n20/D 1.4888(lit.)
| [Fp ]
210 °F
| [storage temp. ]
Keep in dark place,Inert atmosphere,Room temperature | [form ]
clear liquid | [pka]
2.58±0.12(Predicted) | [color ]
Colorless to Light orange to Yellow | [InChIKey]
UTUYWZJPVLDHJJ-UHFFFAOYSA-N |
Hazard Information | Back Directory | [Uses]
4-(Trifluoromethyl)-N-methylaniline is used in the synthesis of Tasquinimod (T007820), an orally active antiangiogenic agent which may inhibit HDAC4 signalling. This affects cancer cell survival thus making this compound and anti-cancer agent. |
|
|